Publicaciones (8) Publicaciones de MARIA MERCEDES ALONSO CASCON

2012

  1. Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 302, Núm. 7

2006

  1. TDZD's: Selective and ATP Noncompetitive Glycogen Synthase Kinase 3 Inhibitors

    Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (John Wiley and Sons Inc.), pp. 257-280

  2. TDZD's: Selective and ATP Noncompetitive Glycogen Synthase Kinase 3 Inhibitors

    Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development (John Wiley & Sons, Inc.), pp. 257-280

2005

  1. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor γ activation

    Journal of Biological Chemistry, Vol. 280, Núm. 22, pp. 21453-21462

  2. SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:  Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

    Journal of Medicinal Chemistry, Vol. 48, Núm. 23, pp. 7103-7112

2004

  1. GSK-3 inhibitors: Discoveries and developments

    Current Medicinal Chemistry, Vol. 11, Núm. 6, pp. 755-763

2002

  1. First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

    Journal of Medicinal Chemistry, Vol. 45, Núm. 6, pp. 1292-1299

  2. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

    Medicinal Research Reviews, Vol. 22, Núm. 4, pp. 373-384